Age Verification Required

Imperial Peptides

By entering this site you confirm that:

  • You are 18 years of age or older
  • All products are for research purposes only — not for human consumption
  • You are a qualified researcher, scientist, or licensed professional
  • You understand these compounds are not approved by the FDA for human use

This confirmation is stored locally and will not be requested again on this device.

We are currently accepting pre-orders to ensure we have the right products in stock to best serve our customers. If you are interested in a product we do not currently carry, please do not hesitate to reach out — we welcome all product requests.
Back to Research Library
Weight Loss

Semaglutide

GLP-1 Receptor Agonist

A glucagon-like peptide-1 (GLP-1) receptor agonist studied for metabolic and glycemic research.

Overview

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 94% homologous analogue of human GLP-1, modified to extend its half-life. Research has extensively studied its effects on glucose metabolism, insulin secretion, appetite regulation, and body weight.

Research Information

Extensive research on semaglutide has demonstrated its ability to stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, and slow gastric emptying. Studies have shown significant effects on appetite regulation through central nervous system pathways. Research has also explored cardiovascular outcomes.

Research Dosage Reference

Research protocols vary widely. Standard vials contain 2mg or 5mg lyophilized powder. All dosing information is for research reference only.

Ready to Order?

Purchase high-purity Semaglutide for your research.

Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.